Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$135K FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 822%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2023, FY2024). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $0.08 today, the market must believe free cash flow compounds 41.6%/yr for a decade (off $61K on the 3-yr avg basis).
Default is 8.8% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.21B shares (market data) · net debt -$285K
mean 78.3% · volatility σ 285% · implied rate exceeded in 3/5 yrs
Central path = implied 41.6%/yr growth; shaded band = ±1σ (285%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PG | $374.5B | 24.4× | 17.8× | 4.3× | 3.3% | 50.2% | 18.4% | 29.5% | 18.1% | 1.5× | 1,518 |
| ECL | $84.9B | 41.6× | 27.1× | 5.3× | 2.2% | 44.5% | 12.9% | 21.2% | 11.5% | 2.2× | 541 |
| CL | $76.0B | 36.2× | 21.0× | 3.7× | 1.4% | 60.1% | 10.5% | — | 26.5% | 1.7× | 646 |
| EL | $39.6B | 218.5× | 25.4× | 2.6× | 5.0% | 75.5% | 1.2% | 4.8% | 4.2% | 0.3× | 224 |
| KVUE | $37.1B | 25.4× | 12.6× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.1× | 257 |
| CHD | $25.4B | 35.5× | 20.6× | 4.1× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.4× | 287 |
| CLX | $10.6B | 13.5× | — | 1.5× | 0.2% | 45.2% | 11.4% | 252% | 28.9% | — | 312 |
| ELF | $6.6B | 253.8× | 46.9× | 4.0× | 24.6% | 70.7% | 1.6% | 2.3% | 1.3% | 3.8× | 102 |
| IPAR | $3.7B | 22.2× | 13.1× | 2.5× | 2.5% | 63.6% | 11.3% | 19.1% | 16.6% | 0.4× | 61 |
| COTY | $3.0B | — | 14.6× | 0.5× | -1.5% | 62.9% | -10.4% | -20.2% | -10.0% | 7.2× | 62 |
| SCL | $1.6B | 34.0× | 10.2× | 0.7× | 7.0% | 11.6% | 2.0% | 3.8% | 2.5% | 2.4× | 49 |
| EPC | $1.3B | 53.9× | 14.6× | 0.6× | -1.3% | 41.6% | 1.1% | 1.6% | 0.9% | 7.5× | 48 |
| ODD | $1000M | 12.0× | 4.6× | 1.2× | 25.2% | 72.7% | 13.7% | 27.9% | 27.9% | -3.1× | 25 |
| WALD | $108M | — | — | 0.4× | -0.7% | 67.3% | -84.4% | -49.7% | -38.4% | — | — |
| DQWS | $17M | — | — | 6.0× | -6.2% | 19.3% | -2.6% | 822% | 822% | -6.6× | — |
Peers = companies sharing DQWS's sector (Perfumes, Cosmetics & Other Toilet Preparations) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9M 100.0% | $3.1M 100.0% | $1.5M 100.0% | $1.8M 100.0% | $2.0M 100.0% | $1.3M 100.0% | $274K 100.0% | $220K 100.0% | $181K 100.0% | $137K 100.0% |
| Cost of Revenue | $2.4M 80.7% | $2.5M 80.0% | $1.1M 75.6% | $1.4M 75.9% | $1.5M 74.5% | $980K 72.7% | $182K 66.5% | $178K 81.0% | $36K 19.9% | $65K 47.3% |
| Gross Profit | $565K 19.3% | $623K 20.0% | $359K 24.4% | $445K 24.1% | $499K 25.5% | $367K 27.3% | $92K 33.5% | $42K 19.0% | $145K 80.1% | $72K 52.7% |
| Selling, General & Admin | $631K 21.6% | $604K 19.4% | $368K 25.0% | $402K 21.8% | $309K 15.8% | $288K 21.4% | $242K 88.5% | $237K 107.5% | $205K 112.8% | $395K 287.8% |
| Total Operating Expenses | — | — | — | — | — | — | $95K 34.6% | $138K 62.8% | $167K 91.8% | $170K 124.1% |
| Operating Income | -$1K -0.0% | -$1K -0.0% | -$1K -0.1% | -$1K -0.1% | -$1K -0.1% | -$1K -0.1% | $295K 108.0% | — | — | — |
| Other Income (Expense), net | — | — | — | — | — | — | -$56K -20.6% | -$46K -21.1% | -$60K -33.1% | -$23K -16.9% |
| Pretax Income | -$61K -2.1% | $30K 1.0% | -$49K -3.3% | -$2K -0.1% | $150K 7.7% | $30K 2.2% | -$295K -108.0% | -$371K -168.7% | -$285K -157.1% | -$516K -376.2% |
| Income Tax Expense | $16K 0.5% | $8K 0.3% | $657 0.0% | $516 0.0% | $176 0.0% | $3K 0.2% | — | — | — | — |
| Net Income | -$77K -2.6% | $22K 0.7% | -$50K -3.4% | -$3K -0.2% | $150K 7.7% | $27K 2.0% | -$295K -108.0% | -$371K -168.7% | -$285K -157.1% | -$516K -376.2% |
| Per Share | ||||||||||
| EPS (Basic) | -$0.00 | $0.00 | -$0.00 | -$0.00 | $0.00 | — | — | — | — | — |
| EPS (Diluted) | -$0.00 | $0.00 | -$0.00 | -$0.00 | — | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 206.9M | 206.9M | 206.9M | 206.9M | 206.9M | — | — | — | — | — |
| Weighted Avg Shares (Diluted) | 206.9M | 206.9M | 206.9M | 206.9M | — | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 9-yr range · 52th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 9-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 822% against ROIC 822% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is -237.6% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 81.0 | 66.5 | 72.7 | 74.5 | 75.9 | 75.6 | 80.0 | 80.7 |
| Gross Profit | 19.0 | 33.5 | 27.3 | 25.5 | 24.1 | 24.4 | 20.0 | 19.3 |
| SG&A | 107.5 | 88.5 | 21.4 | 15.8 | 21.8 | 25.0 | 19.4 | 21.6 |
| Operating Income | — | 108.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.0 | -0.0 |
| Income Tax | — | — | 0.2 | 0.0 | 0.0 | 0.0 | 0.3 | 0.5 |
| Net Income | -168.7 | -108.0 | 2.0 | 7.7 | -0.2 | -3.4 | 0.7 | -2.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DQWS: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 52.7% | -359.2% | -376.2% |
| FY2017 | 80.1% | -123.9% | -157.1% |
| FY2018 | 19.0% | -147.6% | -168.7% |
| FY2019 | 33.5% | 108.0% | -108.0% |
| FY2020 | 27.3% | -0.1% | 2.0% |
| FY2021 | 25.5% | -0.1% | 7.7% |
| FY2022 | 24.1% | -0.1% | -0.2% |
| FY2023 | 24.4% | -0.1% | -3.4% |
| FY2024 | 20.0% | -0.0% | 0.7% |
| FY2025 | 19.3% | -0.0% | -2.6% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Converts 2.27x of reported profit into cash — adequate, without much margin.
Only 3 profitable years available, so the average is shorter than the five the threshold assumes.
Missing from our data, so excluded from this answer: share_based_compensation.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: interest_expense.
At $0.08, free cash flow must compound 41.85%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 233.4% | 41.8% |
| FY2022 | −95.8% | 41.8% |
| FY2023 | 457.9% | 41.8% |
| FY2024 | 71.4% | 41.8% |
| FY2025 | −275.7% | 41.8% |
The implied rate has been matched or beaten in 3 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | −$76,860 | −$76,860 |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$17,443 | −$94,303 |
| Operating cash flow | −$94,303 | −$94,303 |
| Capex | −$41,031 | −$135,334 |
| Free cash flow | −$135,334 | −$135,334 |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 392.5% | 9.6% | -382.8 points |
| FY2021 | 45.3% | -77.5% | -122.9 points |
| FY2022 | -5.6% | 752.0% | 757.6 points |
| FY2023 | -20.5% | 106.7% | 127.2 points |
| FY2024 | 111.8% | 106.5% | -5.2 points |
| FY2025 | -6.2% | -76.7% | -70.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 11.1 days | 34.5 days | 0.9 days | 44.7 days |
| FY2020 | 2.5 days | 14.1 days | 0.5 days | 16.2 days |
| FY2021 | 0.4 days | 4.3 days | 2.7 days | 1.9 days |
| FY2022 | 3.5 days | 1.9 days | 7.7 days | -2.3 days |
| FY2023 | 9 days | 2.3 days | 32.6 days | -21.4 days |
| FY2024 | 8.8 days | 0.5 days | 22.4 days | -13.2 days |
| FY2025 | 2.2 days | 0.4 days | 17.5 days | -15 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -31.6 percent |
| FY2020 | -9.2 percent |
| FY2021 | -20.4 percent |
| FY2022 | -6.6 percent |
| FY2023 | -25.8 percent |
| FY2024 | -25.2 percent |
| FY2025 | 2.6 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.